Biotherapeutics by Design

At Eleven Biotherapeutics we create novel and differentiated biotherapeutics:  first-of-a-kind protein-based drugs with significantly improved physical, pharmaceutical, and therapeutic benefits.  Our AMP-Rx™ product engine brings capabilities beyond conventional approaches for making protein therapeutics, opening up new territory for the products to have novel structures, enhanced biophysical properties, and more effective targeting in disease pathways.  Eleven’s success is built on designing proteins ‘fit for purpose’ that are rationally designed to have ideal therapeutic characteristics and result in best-in-class biotherapeutic products for a wide range of diseases.